PL1729797T3 - Doustne kompozycje farmaceutyczne produktów zawierających lipazę, a zwłaszcza pankreatynę, zawierające środki powierzchniowo czynne - Google Patents
Doustne kompozycje farmaceutyczne produktów zawierających lipazę, a zwłaszcza pankreatynę, zawierające środki powierzchniowo czynneInfo
- Publication number
- PL1729797T3 PL1729797T3 PL05733481T PL05733481T PL1729797T3 PL 1729797 T3 PL1729797 T3 PL 1729797T3 PL 05733481 T PL05733481 T PL 05733481T PL 05733481 T PL05733481 T PL 05733481T PL 1729797 T3 PL1729797 T3 PL 1729797T3
- Authority
- PL
- Poland
- Prior art keywords
- lipase
- pancreatin
- pharmaceutical compositions
- oral pharmaceutical
- containing products
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55499304P | 2004-03-22 | 2004-03-22 | |
EP04101164.4A EP1579869A1 (de) | 2004-03-22 | Pharmazeutische Zusammensetzung enthaltend Lipase, insbesondere Pankreatin, und Tenside | |
EP05733481A EP1729797B1 (en) | 2004-03-22 | 2005-03-21 | Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
PCT/EP2005/051295 WO2005092370A1 (en) | 2004-03-22 | 2005-03-21 | Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1729797T3 true PL1729797T3 (pl) | 2009-02-27 |
Family
ID=34964300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05733481T PL1729797T3 (pl) | 2004-03-22 | 2005-03-21 | Doustne kompozycje farmaceutyczne produktów zawierających lipazę, a zwłaszcza pankreatynę, zawierające środki powierzchniowo czynne |
Country Status (15)
Country | Link |
---|---|
US (3) | US8802087B2 (pl) |
EP (1) | EP1729797B1 (pl) |
JP (1) | JP5032300B2 (pl) |
CN (1) | CN1933850B (pl) |
AT (1) | ATE407693T1 (pl) |
AU (1) | AU2005227090B2 (pl) |
BR (1) | BRPI0509148B8 (pl) |
CA (1) | CA2560613C (pl) |
DE (1) | DE602005009677D1 (pl) |
ES (1) | ES2314646T3 (pl) |
HK (1) | HK1101342A1 (pl) |
PL (1) | PL1729797T3 (pl) |
PT (1) | PT1729797E (pl) |
RU (1) | RU2381813C2 (pl) |
WO (1) | WO2005092370A1 (pl) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
WO2007014896A1 (en) | 2005-07-29 | 2007-02-08 | Solvay Pharmaceuticals Gmbh | Processes for the manufacture of sterilized pancreatin powder |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US20080058282A1 (en) | 2005-08-30 | 2008-03-06 | Fallon Joan M | Use of lactulose in the treatment of autism |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
DE102006001554A1 (de) * | 2006-01-05 | 2007-07-12 | Ipc Process-Center Gmbh & Co. | Micropellets für die Herstellung von Tiernahrungspellets |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
KR20090101930A (ko) | 2006-12-21 | 2009-09-29 | 노보자임스 에이/에스 | 약학적 사용을 위한 리파아제 변형체 |
PL2079445T3 (pl) | 2007-02-20 | 2016-04-29 | Allergan Pharmaceuticals Int Ltd | Stabilne kompozycje enzymów trawiennych |
US20090130063A1 (en) * | 2007-11-15 | 2009-05-21 | Solvay Pharmaceuticals Gmbh | Process for separating and determining the viral load in a pancreatin sample |
US10087493B2 (en) | 2008-03-07 | 2018-10-02 | Aptalis Pharma Canada Ulc | Method for detecting infectious parvovirus in pharmaceutical preparations |
US8658163B2 (en) | 2008-03-13 | 2014-02-25 | Curemark Llc | Compositions and use thereof for treating symptoms of preeclampsia |
US8084025B2 (en) | 2008-04-18 | 2011-12-27 | Curemark Llc | Method for the treatment of the symptoms of drug and alcohol addiction |
US11016104B2 (en) | 2008-07-01 | 2021-05-25 | Curemark, Llc | Methods and compositions for the treatment of symptoms of neurological and mental health disorders |
US10776453B2 (en) | 2008-08-04 | 2020-09-15 | Galenagen, Llc | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain |
EP2165717A1 (de) | 2008-08-27 | 2010-03-24 | Nordmark Arzneimittel GmbH & Co.KG | Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte |
CA2747703C (en) | 2009-01-06 | 2021-06-15 | Curemark Llc | Compositions and methods for the treatment or the prevention of infections by e. coli |
AU2010203709B2 (en) | 2009-01-06 | 2014-05-22 | Galenagen, Llc | Compositions and methods for the treatment or prevention of Staphylococcus Aureus infections and for the Eradication or reduction of Staphylococcus Aureus on surfaces |
SI2391382T1 (sl) * | 2009-01-29 | 2014-10-30 | Nordmark Arzneimittel Gmbh & Co. Kg | Farmacevtski pripravek, ki vsebuje lipazo bakterijskega izvora |
US9056050B2 (en) | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
PL2295039T5 (pl) * | 2009-08-28 | 2023-02-27 | Nordmark Pharma Gmbh | Sposób wytwarzania granulek zawierających pankreatynę, w szczególności mikrogranulek zawierających pankreatynę, oraz wytworzone tym sposobem granulki zawierające pankreatynę |
US8784884B2 (en) | 2009-09-17 | 2014-07-22 | Stephen Perrett | Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency |
KR101968457B1 (ko) | 2010-10-01 | 2019-04-11 | 앨러간 파마슈티컬스 인터내셔널 리미티드 | 장용 코팅된 저 강도 췌장 리파제 제제 |
PL2489349T3 (pl) | 2011-02-17 | 2014-09-30 | Nordmark Arzneimittel Gmbh & Co Kg | Granulki pankreatynowe, zwłaszcza mikrogranulki pankreatynowe, oraz sposób ich produkcji |
JP5976100B2 (ja) | 2011-04-21 | 2016-08-23 | キュアマーク リミテッド ライアビリティ カンパニー | 神経精神障害の処置のための化合物 |
RU2016119726A (ru) | 2011-08-08 | 2018-11-02 | Апталис Фарма Лтд. | Способ проведения теста на растворение твердых композиций, содержащих пищеварительные ферменты |
US8268305B1 (en) | 2011-09-23 | 2012-09-18 | Bio-Cat, Inc. | Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
CN108578684A (zh) * | 2012-01-03 | 2018-09-28 | 柯尔马克有限责任公司 | 治疗神经和精神障碍的行为症状的方法 |
US9668474B2 (en) | 2012-02-10 | 2017-06-06 | Stepan Company | Structured surfactant suspending systems |
US10350278B2 (en) | 2012-05-30 | 2019-07-16 | Curemark, Llc | Methods of treating Celiac disease |
EP2925367B1 (en) * | 2013-01-14 | 2019-08-14 | InFirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US10184121B2 (en) | 2013-06-28 | 2019-01-22 | Allergan Pharmaceuticals International Limited | Methods for removing viral contaminants from pancreatic extracts |
ES2784227T3 (es) | 2013-08-09 | 2020-09-23 | Allergan Pharmaceuticals Int Ltd | Composición de enzimas digestivos adecuada para la administración entérica |
JP2014193909A (ja) * | 2014-06-04 | 2014-10-09 | Nordmark Arzneimittel Gmbh & Co Kg | 医薬調製物 |
TR201704471T1 (tr) * | 2014-11-05 | 2018-04-24 | Abbott Gmbh & Co Kg | Pankreatin İhtiva Eden İyileştirilmiş Güvenlik Profiline Sahip Bileşimlerin Üretilmesi İçin Prosesler Ve Farmasötik Kullanıma Uygun Bileşimler |
US10739353B2 (en) * | 2014-12-31 | 2020-08-11 | Signpath Pharma, Inc. | Suppression of cytokine release and cytokine storm |
US20180028454A1 (en) * | 2015-02-04 | 2018-02-01 | Abbvie Inc. | Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency |
CN104730014B (zh) * | 2015-03-27 | 2017-08-04 | 宁波博泰生物技术有限公司 | 一种血清脂肪酶测定试剂盒及其制备方法 |
DE102015114862A1 (de) * | 2015-09-04 | 2017-03-09 | Nordmark Arzneimittel Gmbh & Co. Kg | Pharmazeutische Zusammensetzung, enthaltend eine bakterielle Lipase |
CA3050082A1 (en) | 2016-04-04 | 2017-10-12 | Omeza LLC | Fish oil topical composition |
US10836890B2 (en) * | 2017-01-25 | 2020-11-17 | Nano And Advanced Materials Institute Limited | Mechanically reinforced, transparent, anti-biofouling thermoplastic resin composition and manufacturing method thereof |
DE102017104472A1 (de) | 2017-03-03 | 2018-09-06 | Nordmark Arzneimittel Gmbh & Co. Kg | Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung |
CN110075279A (zh) * | 2019-04-25 | 2019-08-02 | 淮安麦德森制药有限公司 | 胰酶微球及其生产方法 |
RU2706003C1 (ru) * | 2019-09-09 | 2019-11-13 | Акционерное общество "АВВА РУС" | Микрогранулы, содержащие панкреатин |
US20210236629A1 (en) * | 2020-02-05 | 2021-08-05 | Jubilant Pharma Holdings Inc. | Self-emulsifying dosage forms of allergen and their preparation thereof |
US11541009B2 (en) | 2020-09-10 | 2023-01-03 | Curemark, Llc | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses |
EP4082518A1 (en) * | 2021-04-28 | 2022-11-02 | Cnce Innovacion, S.L. | Fatty acid compositions for the treatment and prevention of hair loss and alopecia |
US20230190888A1 (en) * | 2021-12-16 | 2023-06-22 | First Wave BioPharma, Inc. | Stable lipase formulations and methods thereof |
Family Cites Families (149)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3324002A (en) | 1962-09-17 | 1967-06-06 | Armour Pharma | Anti-inflammatory preparations containing proteolytic enzymes and adrenal glucocorticoids |
US3803305A (en) | 1962-12-28 | 1974-04-09 | Rolland A Lab | Process for obtaining extracts from pancreas |
US3956483A (en) | 1968-10-24 | 1976-05-11 | Wilson Pharmaceutical & Chemical Corporation | Preparing pancreatin |
DE2035739A1 (en) | 1970-07-18 | 1972-01-27 | Röhm FmbH, 6100 Darmstadt | Oral enzyme prepsn - consisting of granulate with gastric juices-resistant coating in tablet or capsule form |
US3991180A (en) | 1972-03-06 | 1976-11-09 | Rohm And Haas Company | Stabilization of internally administered pancreatic lipase |
FR2183546B1 (pl) | 1972-05-10 | 1975-06-20 | Servier Lab | |
DE2410241A1 (de) | 1974-03-04 | 1975-09-18 | Christian Brunnengraeber Chem | Granulataehnliche darreichungsform fuer arzneimittel |
DE2512746C3 (de) | 1975-03-22 | 1980-04-24 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin |
US3986927A (en) | 1975-04-28 | 1976-10-19 | Armour Pharmaceutical Company | Process for the purification and sterilization of acidophilic biologicals by extreme acidification at cold temperatures |
GB1509866A (en) | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
GB1590432A (en) | 1976-07-07 | 1981-06-03 | Novo Industri As | Process for the production of an enzyme granulate and the enzyme granuate thus produced |
GB1603640A (en) | 1977-07-20 | 1981-11-25 | Gist Brocades Nv | Enzyme particles |
JPS5535031A (en) | 1978-09-04 | 1980-03-11 | Shin Etsu Chem Co Ltd | Enteric coating composition |
US4259440A (en) | 1979-05-21 | 1981-03-31 | Miles Laboratories, Inc. | Hydrolysis and assay of triglycerides |
DE2923279B1 (de) | 1979-06-08 | 1980-11-20 | Kali Chemie Pharma Gmbh | Verfahren zur Herstellung von Pankreatin-Pellets |
JPS5855125B2 (ja) | 1980-03-10 | 1983-12-08 | 信越化学工業株式会社 | 固形薬剤用腸溶性コ−テイング剤組成物 |
JPS57171428A (en) | 1981-04-13 | 1982-10-22 | Sankyo Co Ltd | Preparation of coated solid preparation |
EP0115023B1 (de) | 1982-12-30 | 1988-07-27 | Nordmark Arzneimittel GmbH | Verfahren zur Gewinnung von Pankreatin |
US4447412A (en) | 1983-02-01 | 1984-05-08 | Bilton Gerald L | Enzyme-containing digestive aid compostions |
IE55711B1 (en) | 1983-10-24 | 1990-12-19 | Bausch & Lomb | Improved method for enzymatic cleaning and disinfecting contact lenses |
US4490361A (en) | 1983-12-02 | 1984-12-25 | Alpha Therapeutic Corporation | Virus inactivating heat treatment of plasma fractions |
DK263584D0 (da) | 1984-05-29 | 1984-05-29 | Novo Industri As | Enzymholdige granulater anvendt som detergentadditiver |
US4689297A (en) | 1985-03-05 | 1987-08-25 | Miles Laboratories, Inc. | Dust free particulate enzyme formulation |
US4707287A (en) | 1985-06-28 | 1987-11-17 | The Procter & Gamble Company | Dry bleach stable enzyme composition |
US4775536A (en) | 1986-02-24 | 1988-10-04 | Bristol-Myers Company | Enteric coated tablet and process for making |
US5766912A (en) | 1986-03-17 | 1998-06-16 | Novo Nordisk A/S | Humicola lipase produced in aspergillus |
US5874558A (en) | 1986-03-17 | 1999-02-23 | Novo Nordisk | Nucleic acid encoding a recombinant humicola sp. lipase |
US5536661A (en) | 1987-03-10 | 1996-07-16 | Novo Nordisk A/S | Process for the production of protein products in aspergillus |
DK122686D0 (da) | 1986-03-17 | 1986-03-17 | Novo Industri As | Fremstilling af proteiner |
GB2189698A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
EP0270608B1 (en) | 1986-05-21 | 1990-08-22 | Novo Nordisk A/S | Coated detergent enzymes |
DE3642853A1 (de) | 1986-12-16 | 1988-06-23 | Ulrich Von Dr Ing Pidoll | Arzneimittel |
DK435687D0 (da) | 1987-08-21 | 1987-08-21 | Novo Industri As | Enzymholdigt granulat og fremgangsmaade til fremstilling deraf |
DK435587D0 (da) | 1987-08-21 | 1987-08-21 | Novo Industri As | Fremgangsmaade til fremstilling af et enzymholdigt granulat |
EP0305216B1 (en) | 1987-08-28 | 1995-08-02 | Novo Nordisk A/S | Recombinant Humicola lipase and process for the production of recombinant humicola lipases |
US5068110A (en) | 1987-09-29 | 1991-11-26 | Warner-Lambert Company | Stabilization of enteric coated dosage form |
IL88961A (en) | 1988-01-29 | 1992-07-15 | Basf Ag | Stable mixtures containing oxidation-sensitive compounds |
WO1989008694A1 (en) | 1988-03-14 | 1989-09-21 | Novo-Nordisk A/S | Granulate detergent enzyme product, method for production thereof, use thereof, and detergent containing such product |
DK78189D0 (da) | 1989-02-20 | 1989-02-20 | Novo Industri As | Enzymholdigt granulat og fremgangsmaade til fremstilling deraf |
DK78089D0 (da) | 1989-02-20 | 1989-02-20 | Novo Industri As | Detergentholdigt granulat og fremgangsmaade til fremstilling deraf |
US5219572A (en) | 1989-03-17 | 1993-06-15 | Pitman-Moore, Inc. | Controlled release delivery device for macromolecular proteins |
CA2034489C (en) | 1989-06-15 | 1996-07-16 | Michael E. Hrinda | Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
US5658871A (en) | 1989-07-07 | 1997-08-19 | Lever Brothers Company, Division Of Conopco, Inc. | Microbial lipase muteins and detergent compositions comprising same |
GB8915658D0 (en) | 1989-07-07 | 1989-08-23 | Unilever Plc | Enzymes,their production and use |
AU6719090A (en) | 1989-10-31 | 1991-05-31 | Genencor International, Inc. | Dust-free coated enzyme formulation |
GB9007052D0 (en) | 1990-03-29 | 1990-05-30 | Skua Investments Ltd | Pharmaceutical formulations |
US6187572B1 (en) | 1990-04-16 | 2001-02-13 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants |
DK173590D0 (da) | 1990-06-06 | 1990-07-19 | Novo Nordisk As | Rekombinante terapeutiske lipaser |
CA2087730C (en) | 1990-08-03 | 1999-07-20 | Manuel A. Navia | Use of crosslinked crystals as a novel form of enzyme immobilization |
US5618710A (en) | 1990-08-03 | 1997-04-08 | Vertex Pharmaceuticals, Inc. | Crosslinked enzyme crystals |
US5801022A (en) | 1990-08-03 | 1998-09-01 | Vertex Pharmaceuticals, Incorporated | Method of producing a product with crosslinked crystals of thermolysin |
US5869438A (en) | 1990-09-13 | 1999-02-09 | Novo Nordisk A/S | Lipase variants |
CA2055572A1 (en) * | 1990-12-18 | 1992-06-19 | David Kronenthal | Processes and intermediates for thromboxane receptor antagonists |
US5254283A (en) | 1991-01-17 | 1993-10-19 | Genencor International, Inc. | Isophthalic polymer coated particles |
AU661297B2 (en) | 1991-01-24 | 1995-07-20 | Martek Corporation | Microbial oil mixtures and uses thereof |
DK13491D0 (da) | 1991-01-25 | 1991-01-25 | Novo Nordisk As | Anvendelse af et enzymholdigt granulat og fremgangsmaade til fremstilling af et forderstof i tabletform |
DE4203315A1 (de) | 1991-02-14 | 1992-08-20 | Kali Chemie Pharma Gmbh | Verfahren zur gewinnung von pankreatin |
DE59209604D1 (de) | 1991-07-01 | 1999-02-11 | Basf Ag | Verwendung von lipasen zur herstellung von arzneimitteln |
US5225202A (en) | 1991-09-30 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Enteric coated pharmaceutical compositions |
US5879920A (en) | 1991-10-07 | 1999-03-09 | Genencor International, Inc. | Coated enzyme-containing granule |
US5324649A (en) | 1991-10-07 | 1994-06-28 | Genencor International, Inc. | Enzyme-containing granules coated with hydrolyzed polyvinyl alcohol or copolymer thereof |
WO1993007260A1 (en) | 1991-10-10 | 1993-04-15 | Genencor International, Inc. | Process for dust-free enzyme manufacture |
DE4200002A1 (de) | 1992-01-02 | 1993-07-08 | Rudolf V Dipl Chem Dr Noronha | Reinigungstablette fuer die zahnprothesen |
US5260074A (en) | 1992-06-22 | 1993-11-09 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
US5302400A (en) | 1992-06-22 | 1994-04-12 | Digestive Care Inc. | Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids |
DE4227385A1 (de) | 1992-08-19 | 1994-02-24 | Kali Chemie Pharma Gmbh | Pankreatinmikropellets |
WO1994008605A1 (en) | 1992-10-16 | 1994-04-28 | Smithkline Beecham Corporation | Therapeutic microemulsions |
JPH08502490A (ja) | 1992-10-16 | 1996-03-19 | スミスクライン・ビーチャム・コーポレイション | 組成物 |
JP3264027B2 (ja) | 1993-02-24 | 2002-03-11 | ソニー株式会社 | 放電セル及びその製造方法 |
DK39693D0 (da) | 1993-04-02 | 1993-04-02 | Novo Nordisk As | Enzym |
DE4322229A1 (de) | 1993-07-05 | 1995-01-12 | Cognis Bio Umwelt | Umhüllte Enzymzubereitung für Wasch- und Reinigungsmittel |
CA2168870A1 (en) | 1993-09-15 | 1995-03-23 | Anthony Vincent Rawlings | Skin care method and composition |
FR2710535B1 (fr) * | 1993-09-30 | 1995-11-24 | Gattefosse Ets Sa | Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion. |
US6054136A (en) | 1993-09-30 | 2000-04-25 | Gattefosse S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
US6312704B1 (en) | 1993-09-30 | 2001-11-06 | Gattefosse, S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
DE4344215A1 (de) | 1993-12-23 | 1995-06-29 | Cognis Bio Umwelt | Silberkorrosionsschutzmittelhaltige Enzymzubereitung |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
DE4422198C2 (de) | 1994-06-24 | 1997-08-28 | Audi Ag | Verfahren zum Steuern der elektrischen Beheizung eines Katalysators |
JP3355593B2 (ja) * | 1994-08-19 | 2002-12-09 | 信越化学工業株式会社 | 固形腸溶製剤の製造方法 |
CA2205610A1 (en) | 1994-11-18 | 1996-05-30 | Genencor International, Inc. | Coated enzyme granules |
DK0773984T3 (da) | 1995-05-29 | 2000-04-10 | Kao Corp | Enzymholdig granuleret substans og fremgangsmåde til fremstilling heraf |
ES2236738T3 (es) | 1995-05-31 | 2005-07-16 | Medzyme N.V. | Composicion para mejorar la digestibilidad y la utilizacion de nutrientes. |
WO1997023605A1 (en) | 1995-12-22 | 1997-07-03 | Helix Biotechnology Ltd. | Thermostable proteolytic enzyme from thermoactinomyces thalpophilus thm1 |
ID18663A (id) | 1996-04-12 | 1998-04-30 | Novartis Ag | Komposisi farmasi berlapis enterik |
EP0910631B1 (en) | 1996-04-12 | 2005-03-16 | Novozymes A/S | Enzyme-containing granules and process for the production thereof |
ATE365208T1 (de) | 1996-04-29 | 2007-07-15 | Novozymes As | Flüssige, nichtwässrige enzyme enthaltende zusammensetzungen |
US5750104A (en) | 1996-05-29 | 1998-05-12 | Digestive Care Inc. | High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith |
GB9613858D0 (en) | 1996-07-02 | 1996-09-04 | Cortecs Ltd | Hydrophobic preparations |
DE19724845A1 (de) | 1996-08-28 | 1998-03-05 | Solvay Pharm Gmbh | Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen |
GB9624927D0 (en) | 1996-11-29 | 1997-01-15 | Oxford Glycosciences Uk Ltd | Gels and their use |
US6140475A (en) | 1997-04-11 | 2000-10-31 | Altus Biologics Inc. | Controlled dissolution crosslinked protein crystals |
AUPO693397A0 (en) | 1997-05-22 | 1997-06-12 | Betatene Limited | Carotenoid formulation |
NZ330940A (en) | 1997-07-24 | 2000-02-28 | F | Production of consensus phytases from fungal origin using computer programmes |
ES2137862B1 (es) | 1997-07-31 | 2000-09-16 | Intexim S A | Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion. |
JP3611456B2 (ja) | 1997-09-30 | 2005-01-19 | 日研化学株式会社 | テオフィリン徐放性錠剤 |
KR19990072826A (ko) | 1998-02-26 | 1999-09-27 | 우재영 | 판크레아틴장용코팅과립의제조방법 |
US20030021844A1 (en) | 1998-03-04 | 2003-01-30 | Philippe Barthelemy | Immediate-release oral pellet comprising polyglycolysed glycerides, and manufacturing process |
FR2775597B1 (fr) | 1998-03-04 | 2001-04-20 | Gattefosse Ets Sa | Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication |
EP1061873B1 (en) | 1998-03-09 | 2005-11-02 | Ista Pharmaceuticals, Inc | Use of glyceraldehyde as corneal hardening agents |
DE29824797U1 (de) | 1998-05-22 | 2002-08-22 | Bristol Myers Squibb Co | Magensaftresistent überzogene Arzneimittel |
UA69413C2 (uk) | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції |
US6268329B1 (en) | 1998-06-30 | 2001-07-31 | Nouozymes A/S | Enzyme containing granule |
ATE255158T1 (de) | 1998-06-30 | 2003-12-15 | Novozymes As | Neues, verbessertes, enzym enthaltendes granulat |
DE19848849A1 (de) | 1998-10-22 | 2000-04-27 | Knoll Ag | Verfahren zur Herstellung von festen, sphärischen Formen, enthaltend eine biologisch aktive Substanz |
DE19856415C2 (de) | 1998-12-08 | 2001-06-07 | Thomas Fenner | Verfahren zur Reinigung bzw. Isolierung viraler Nukleinsäuren |
US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US20030104048A1 (en) * | 1999-02-26 | 2003-06-05 | Lipocine, Inc. | Pharmaceutical dosage forms for highly hydrophilic materials |
US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
RU2268065C2 (ru) | 1999-03-17 | 2006-01-20 | Зольвай Фармасьютиклз Гмбх | Лекарственное средство, предназначенное для лечения диабета |
DE60034885T2 (de) | 1999-05-27 | 2008-01-17 | Amano Enzyme Inc., Nagoya | Enzymlauge und verfahren zu deren herstellung, enzymzubereitung, proteasezubereitungen und proteaseproduzierendes bakterium |
AU7405200A (en) | 1999-10-01 | 2001-05-10 | Novozymes A/S | Spray dried enzyme product |
DK1138333T3 (da) | 1999-10-12 | 2004-05-24 | Daiichi Suntory Pharma Co Ltd | Medicinske præparater til oral anvendelse |
DE60013630T2 (de) | 1999-11-01 | 2005-09-15 | John Cardiff Rhodes | Arzneimittel zur behandlung von darmverstopfung und reizkolon |
US20030180352A1 (en) | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
DE60114766T2 (de) | 1999-12-30 | 2006-07-27 | Kemin Industries, Inc. | Verfahren zur Verbesserung der Aktivität von Enzymen |
MXPA02007614A (es) | 2000-02-08 | 2002-12-13 | Hoffmann La Roche | Uso de proteasas subtilisinas estables en acido para alimento de animales. |
US20010046493A1 (en) | 2000-02-24 | 2001-11-29 | Alex Margolin | Lipase-containing composition and methods of use thereof |
KR20010100194A (ko) | 2000-03-13 | 2001-11-14 | 박호군 | 여러 가지 물질의 가용화용 조성물과 제형 및 그들의제조방법 |
DE10026698A1 (de) * | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
US20020146451A1 (en) | 2000-07-15 | 2002-10-10 | Sharma Virender K. | Method for the administration of acid-labile drugs |
CN1452657A (zh) | 2000-09-08 | 2003-10-29 | 诺和酶股份有限公司 | 润滑颗粒 |
CN1292734C (zh) | 2000-10-02 | 2007-01-03 | 诺和酶股份有限公司 | 含有活性物质的包衣微粒 |
PL204599B1 (pl) | 2000-11-02 | 2010-01-29 | Cilian Ag | Enzymy uzyskane z orzęsków i ich zastosowanie |
IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
AR032392A1 (es) | 2001-01-19 | 2003-11-05 | Solvay Pharm Gmbh | Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado. |
US6692771B2 (en) * | 2001-02-23 | 2004-02-17 | Cima Labs Inc. | Emulsions as solid dosage forms for oral administration |
US6676933B2 (en) | 2001-05-23 | 2004-01-13 | Osmotica Corp. | Pharmaceutical composition containing mosapride and pancreatin |
EP1279402B1 (en) | 2001-07-26 | 2006-11-29 | Ethypharm | Coated granules of allylamine-or benzylamine-anti-mycotics, process for preparation thereof and orodispersible tablets containing said coated granules |
FR2827770B1 (fr) * | 2001-07-27 | 2005-08-19 | Gattefosse Ets Sa | Composition pharmaceutique a usage oral comprenant un principe actif susceptible de subir un important effet de premier passage intestinal |
US6749851B2 (en) | 2001-08-31 | 2004-06-15 | Clearant, Inc. | Methods for sterilizing preparations of digestive enzymes |
EA008072B1 (ru) | 2001-12-03 | 2007-02-27 | Новацея, Инк. | Фармацевтические составы, содержащие соединения активного витамина d |
WO2003055967A1 (en) | 2001-12-21 | 2003-07-10 | Novozymes A/S | Salt coatings |
AU2003214037A1 (en) | 2002-03-27 | 2003-10-08 | Novozymes A/S | Granules with filamentous coatings |
US20040161423A1 (en) | 2002-07-18 | 2004-08-19 | Sanjeev Kumar (Mendiratta) | Polymer modified anti-angiogenic serpins |
EP1592711A1 (en) | 2003-02-06 | 2005-11-09 | Novozymes A/S | Human heavy chain antibody expression in filamentous fungi |
US20040213847A1 (en) | 2003-04-23 | 2004-10-28 | Matharu Amol Singh | Delayed release pharmaceutical compositions containing proton pump inhibitors |
AU2004260961B2 (en) | 2003-07-29 | 2010-05-20 | Abbott Laboratories Gmbh | Analytical method for pancreatin and comparable compositions |
EP1711529A1 (en) | 2004-01-21 | 2006-10-18 | Novozymes A/S | Production of a monoclonal antibody in a heterokaryon fungus or in a fungal host cell |
ITMI20040891A1 (it) | 2004-05-04 | 2004-08-04 | Ibsa Inst Biochimique Sa | Nuovo metodo per la partizione ed inattivazione di contaminanti virali e prionici |
AU2005295754B2 (en) | 2004-10-14 | 2010-09-09 | Eli Lilly And Co. | Compositions containing lipase; protease and amylase for treating pancreatic insufficiency |
EP1896577A2 (en) | 2005-06-24 | 2008-03-12 | Novozymes A/S | Lipases for pharmaceutical use |
WO2007014896A1 (en) | 2005-07-29 | 2007-02-08 | Solvay Pharmaceuticals Gmbh | Processes for the manufacture of sterilized pancreatin powder |
EP1931317B1 (en) | 2005-08-15 | 2008-12-24 | Solvay Pharmaceuticals GmbH | Pancreatin micropellets suitable for enteric coating |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
KR20090101930A (ko) | 2006-12-21 | 2009-09-29 | 노보자임스 에이/에스 | 약학적 사용을 위한 리파아제 변형체 |
US20090130063A1 (en) | 2007-11-15 | 2009-05-21 | Solvay Pharmaceuticals Gmbh | Process for separating and determining the viral load in a pancreatin sample |
US10087493B2 (en) | 2008-03-07 | 2018-10-02 | Aptalis Pharma Canada Ulc | Method for detecting infectious parvovirus in pharmaceutical preparations |
-
2005
- 2005-03-21 WO PCT/EP2005/051295 patent/WO2005092370A1/en active IP Right Grant
- 2005-03-21 RU RU2006137325/15A patent/RU2381813C2/ru active
- 2005-03-21 EP EP05733481A patent/EP1729797B1/en active Active
- 2005-03-21 PL PL05733481T patent/PL1729797T3/pl unknown
- 2005-03-21 ES ES05733481T patent/ES2314646T3/es active Active
- 2005-03-21 AT AT05733481T patent/ATE407693T1/de active
- 2005-03-21 AU AU2005227090A patent/AU2005227090B2/en active Active
- 2005-03-21 BR BRPI0509148A patent/BRPI0509148B8/pt active IP Right Grant
- 2005-03-21 CN CN2005800093147A patent/CN1933850B/zh active Active
- 2005-03-21 CA CA2560613A patent/CA2560613C/en active Active
- 2005-03-21 JP JP2007504411A patent/JP5032300B2/ja active Active
- 2005-03-21 PT PT05733481T patent/PT1729797E/pt unknown
- 2005-03-21 DE DE602005009677T patent/DE602005009677D1/de active Active
- 2005-03-22 US US11/085,073 patent/US8802087B2/en active Active
-
2007
- 2007-06-07 HK HK07106104.3A patent/HK1101342A1/xx unknown
-
2014
- 2014-06-18 US US14/308,543 patent/US20140302000A1/en not_active Abandoned
-
2019
- 2019-05-23 US US16/421,068 patent/US20190275122A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0509148A (pt) | 2007-09-11 |
RU2381813C2 (ru) | 2010-02-20 |
US20190275122A1 (en) | 2019-09-12 |
US20050250817A1 (en) | 2005-11-10 |
JP2007530503A (ja) | 2007-11-01 |
WO2005092370A1 (en) | 2005-10-06 |
CN1933850B (zh) | 2011-01-12 |
CN1933850A (zh) | 2007-03-21 |
ES2314646T3 (es) | 2009-03-16 |
DE602005009677D1 (de) | 2008-10-23 |
ATE407693T1 (de) | 2008-09-15 |
CA2560613A1 (en) | 2005-10-06 |
RU2006137325A (ru) | 2008-04-27 |
AU2005227090B2 (en) | 2010-12-09 |
EP1729797A1 (en) | 2006-12-13 |
AU2005227090A1 (en) | 2005-10-06 |
BRPI0509148B8 (pt) | 2021-05-25 |
EP1729797B1 (en) | 2008-09-10 |
US8802087B2 (en) | 2014-08-12 |
US20140302000A1 (en) | 2014-10-09 |
CA2560613C (en) | 2015-11-24 |
BRPI0509148B1 (pt) | 2016-07-12 |
JP5032300B2 (ja) | 2012-09-26 |
HK1101342A1 (en) | 2007-10-18 |
PT1729797E (pt) | 2008-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1101342A1 (en) | Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants | |
HUP0500560A2 (hu) | Mikróbás enzimek új keverékei | |
WO2008021987A3 (en) | Proteolytic enzyme formulations | |
BRPI0510817A (pt) | protease, uso de uma protease, composição farmacêutica, e, método para o tratamento de uma doença | |
NO20080437L (no) | Lipaser til farmasoytisk anvendelse | |
MX2009006597A (es) | Variantes de lipasa para uso farmaceutico. | |
Fuhrmann et al. | Improving the stability and activity of oral therapeutic enzymes—Recent advances and perspectives | |
WO2011063394A3 (en) | Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions | |
WO1999043651A3 (en) | Inhibitors of phospholipase enzymes | |
WO2002051424A8 (fr) | Medicaments contre les defaillances articulaires | |
WO2002076939A3 (en) | Cysteine protease inhibitors | |
WO2007081755A3 (en) | Indole-benzimidazole and indazole inhibitors of tyrosine phosphatases | |
JO2386B1 (en) | Dispersing compounds containing lipase inhibitors | |
WO2004069138A3 (en) | Pharmaceutical formulation | |
CL2012000658A1 (es) | Composicion farmaceutica que comprende microesferas entericamente recubiertas que contienen enzimas digestivas tal como lipasa y microesferas no recubiertas entericamente que contienen enzimas digestivas tal como proteasa; forma de dosis; y su uso tratar el dolor de pancreatitis e insuficiencia pancreatica. | |
EA201070746A1 (ru) | Фармацевтическая композиция, содержащая по меньшей мере один белковый активный ингредиент, защищенный от расщепления ферментами | |
WO2006017124A3 (en) | Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases | |
MX2010005690A (es) | Variantes de proteasa para uso farmaceutico. | |
EA201070826A1 (ru) | Антитела против pcrv | |
IN2012DN00592A (pl) | ||
DE50106273D1 (de) | Verwendung von aus ciliaten gewonnenen enzymen als verdauungsfördernde arzneimittel | |
WO2005062952A3 (en) | Compositions and methods for modulating sirtuin activity | |
AR030593A1 (es) | Sistema tensioactivo | |
WO2002091926A3 (en) | Inhibitors of dna methyltransferase isoforms | |
CU23065A3 (es) | Metodos y composiciones para inhibir la proliferacion de celulas de mamiferos |